Tirzepatide and Aspirin: Separating the Facts from the Worry

The misconception: aspirin and tirzepatide cannot be taken together

This is the biggest misreading doing the rounds online, and it is worth correcting directly. The concern tends to arise because tirzepatide slows gastric emptying (a well-documented effect of GLP-1 and GIP receptor agonism) and people worry this must interfere with everything they swallow. In reality, the Mounjaro Summary of Product Characteristics does not list aspirin as a contraindicated co-medication, and no formal interaction study has produced evidence of a harmful pharmacokinetic clash between the two. Low-dose aspirin (typically 75mg daily) is taken for cardiovascular protection by a large proportion of the adults who are eligible for tirzepatide in the first place, given the overlap between obesity, cardiovascular disease and metabolic risk. Withholding aspirin therapy because of tirzepatide, or stopping tirzepatide because of aspirin, is not supported by the current evidence base. The decision about whether to continue, adjust or reconsider either medicine rests with your prescriber, who can weigh your personal history properly.

For a broader grounding in how tirzepatide works and what it is licensed for in the UK, the tirzepatide overview covers the mechanism, the trial data and the eligibility criteria in plain terms.

Where the caution is genuinely warranted: gastric effects and absorption timing

That said, this is not a blanket green light either. There are two real areas of nuance. First, tirzepatide's slowing of gastric emptying can delay the rate at which oral medicines are absorbed, not necessarily the total amount absorbed, but the speed. For most people taking aspirin this is clinically unimportant, since low-dose aspirin's protective effect is cumulative rather than dependent on rapid peak levels. Higher doses of aspirin for acute pain relief may be more affected in timing terms, though this is rarely a serious concern. Second, both tirzepatide and aspirin can independently irritate the stomach lining. Nausea, indigestion and reflux are common in the early weeks of tirzepatide treatment, and aspirin is known to carry a small risk of gastric erosion, particularly at higher doses or without food. For most healthy adults these risks do not compound in a clinically significant way. For anyone with a history of peptic ulcer disease, GI bleeding or who takes other NSAIDs, the combination warrants a proper conversation with a prescriber rather than a self-managed decision. A gastro-protective medicine such as a proton pump inhibitor is sometimes already prescribed alongside long-term aspirin use; if you take one, mention it at consultation too.

If you have already been prescribed tirzepatide elsewhere and want specific guidance on aspirin alongside it, our detailed page on taking aspirin with Mounjaro goes further into the practical day-to-day picture.

How a prescriber thinks about other medicines you take

At a consultation for tirzepatide, the prescriber is not just checking a list of absolute contraindications. They are building a picture: which medicines you take regularly, whether any are time-sensitive in their absorption, whether your GI history raises particular flags, and whether your current cardiovascular and metabolic profile makes tirzepatide the right choice in the first place. Aspirin is one of several common co-medications that will come up in that review. Others worth knowing about include oral contraceptives (for which tirzepatide's gastric-emptying effect has led to specific guidance about adding a non-oral backup method for the first four weeks of treatment and after each dose increase) and HRT, where transdermal formulations are generally preferred on tirzepatide for the same absorption reason. The HRT and tirzepatide page covers that ground if it is relevant to you.

The MHRA Drug Safety Updates index is the right place to check for any new safety communications about tirzepatide as they emerge; the regulator publishes updates there when evidence changes.

On the financial side, understanding what a private tirzepatide prescription typically costs is a reasonable part of planning. The Mounjaro prices page explains what the market looks like and what a legitimate prescription service includes, without any hidden fees.

What actually happens when you start treatment with nume

Every consultation at nume is personally read by a GPhC-registered Independent Prescriber, a real clinician, reviewing your full medical and medication history the same day. You list every medicine you take, including aspirin, and the prescriber assesses whether tirzepatide is suitable for you specifically, including for people managing conditions such as multiple sclerosis, where our tirzepatide and MS guidance sets out the specific considerations that apply. There are no automated approvals. If treatment is clinically appropriate and you order before noon on a working day, your prescription is dispensed and dispatched the same day, and you can read about how tirzepatide works at a lifestyle level to get the most from treatment once it begins. The pen arrives with DPD the next working day, in plain unbranded packaging, with tracking on your phone. Aftercare is available seven days a week; if a question about your aspirin use comes up after you start, the clinical team is there to answer it. If you want to explore whether tirzepatide is right for you, start your free consultation and let a prescriber look at the full picture.